PARK

Interested in Park Dental Partners, Inc.? Here are five stocks we like better. Park Dental Partners reported solid second-quarter performance, with revenue up 5.1% to $66.2 million and year-to-date revenue rising 5.6% to $128.9 million. Same-practice revenue increased 2.3% in the quarter, while adjusted EBITDA reached $7.4 million, or 11.2% of revenue. The company raised its revenue outlook for its existing business after first-half results modestly exceeded expectations. Patient retention remained strong at approximately 90.3%, and Park Dental ended the quarter with 219 doctors and $24.4 million in cash. Park Dental plans to acquire Village Family Dental for $39.1 million in base consideration plus up to $6.9 million in contingent payments. The deal, expected to close later in 2026, would add about 48 doctors across 12 North Carolina locations and is expected to be accretive to revenue and adjusted earnings, excluding one-time costs. Park Dental Partners (NASDAQ:PARK) reported second-quarter revenue growth of 5.1% and raised its revenue outlook for its existing business after first-half results came in modestly ahead of management’s expectations. Revenue for the second quarter totaled $66.2 million, while revenue for the first six months of 2026 reached $128.9 million, up 5.6% from the comparable prior-year period. Same-practice revenue increased 2.3% in the quarter and 3.2% year to date. → AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be Chief Executive Officer and Board Chair Pete Swenson said the company’s results were consistent with expectations and reflected continued execution across its dental practices. Patient retention remained above 90%, and the company ended the quarter with 219 doctors. Chief Financial Officer Christopher Bernander said same-practice growth reflected patient demand, reimbursement growth and increased provider capacity. He said the quarterly rate was lower than the prior quarter because of provider scheduling, timing shifts within the year and a more difficult comparison with 2025. Patient visits were approximately 186,000 in the second quarter and 364,000 year to date. Patient retention was approximately 90.3% during the quarter. GAAP net income was approximately $1.3 million, or $0.22 per diluted share, for the quarter. Year-to-date GAAP net income was approximately $1.0 million, or $0.16 per diluted share. Adjusted EBITDA was approximately $7.4 million, equal to 11.2% of revenue, in the quarter. Adjusted diluted earnings per share were approximately $0.66 for the quarter and $1.11 year to date. → Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand Bernander said reported results continued to be affected by share-based compensation and public-company reporting costs compared with the prior-year period. Share-based compensation was approximately $3 million in the quarter and $7.1 million year to date, with more than 90% attributed to doctors. The company expects IPO-related stock compensation expense to decline in coming quarters as GAAP recognition runs off. Park Dental generated approximately $9.7 million of operating cash flow during the first half. It ended the quarter with approximately $24.4 million in cash, $11 million of debt, and an undrawn $15 million revolving credit facility that includes a $10 million accordion feature. → On Holding's Price Stumble May Be an Opening for a Company Built to Run The company recently announced a definitive agreement to acquire Village Family Dental, a North Carolina dental organization that has operated for more than 40 years. Swenson described the proposed combination as an important step in Park Dental’s strategy to enter new markets and grow through affiliations with established dental organizations. Upon closing, Village Family Dental is expected to add approximately 48 doctors across 12 locations in Eastern North Carolina. Swenson said the company plans to preserve the aspects of Village Family Dental’s culture and operating model that have supported its success while providing additional resources and pursuing growth opportunities together. The proposed transaction includes $39.1 million of base consideration and up to $6.9 million of contingent consideration. The contingent amount may be earned based on future performance targets and continued employment by the prior doctor owners for five years, Bernander said. The base consideration is expected to be paid through a mix of cash, debt and stock, with approximately 24% of the consideration in stock. Park Dental expects to use cash on hand and its existing credit facility to complete the transaction later in 2026. Bernander said the acquisition is expected to be accretive to revenue and adjusted earnings, excluding one-time transaction and integration costs. The company’s second-quarter adjusted EBITDA included an approximately $400,000 add-back for legal and other deal costs related to the transaction. Park Dental’s updated outlook does not include any contribution from Village Family Dental because the deal remains subject to closing conditions and integration planning. Management said it would provide updated guidance after the transaction closes. Swenson said Park Dental’s long-term growth plan remains focused on adding doctors to existing practices, affiliating with high-quality practices, selectively developing new locations and expanding into attractive markets. The company completed five acquisitions over the past year, which together contributed approximately $1.3 million of revenue in the second quarter. During the quarter, the company also welcomed Zumbro Family Dental in Rochester, Minnesota. Swenson said the additions of Zumbro and Village Family illustrate Park Dental’s ability to partner with both individual practices in existing markets and larger organizations in new markets. Management said its acquisition pipeline remains active. Swenson said the company continues to evaluate opportunities nationally and remains focused on building scale in Arizona. He also said Village Family Dental has a history of acquisition-driven growth, which could provide additional opportunities after closing. In response to analyst questions, Swenson said integration planning for Village Family Dental is already underway. He said Village Family is a sophisticated organization with its own resources and that the companies expect to identify best practices across both organizations. Swenson also said the company continues to invest in developing internal leadership. In June, a group of 10 doctors completed Park Dental’s year-and-a-half doctor leadership program, which management said is intended to maintain meaningful doctor participation in the organization’s leadership as it grows. Park Dental Partners (NASDAQ: PARK) is a dental support organization that provides business and administrative services to affiliated dental practices. The company focuses on enabling dental clinicians to concentrate on patient care by delivering centralized non-clinical functions that support day-to-day operations and practice growth. Services typically offered by Park Dental Partners include practice management, billing and revenue cycle management, procurement and supply-chain support, information technology, human resources, marketing and patient acquisition, and regulatory and compliance assistance. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Park Dental Partners Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

MINNEAPOLIS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its second quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables. Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors "We delivered another quarter of revenue growth, supported by positive same-practice performance, strong patient retention, and continued expansion of our affiliated doctor base. Our underlying operations are preforming well and generated strong operating cash flows during the quarter. Patient demand across both general and specialty services remains resilient, and we continue investing in recruiting, staffing, clinical capacity, and strategic growth initiatives designed to support long-term value creation. Our balance sheet remains strong, providing flexibility to pursue disciplined acquisitions, support de novo expansion opportunities, and continue investing in our affiliated practices.” Financial Results Revenue increased 5.1% to $66.2 million for the second quarter of 2026, compared to $63.0 million in the prior-year period. For the first six months of 2026, revenue increased 5.6% to $128.9 million, compared to $122.0 million in the prior-year period. The increases were primarily driven by acquisitions completed since the comparable prior-year periods, favorable reimbursement trends, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.3 million in the quarter and $2.0 million year-to-date. Gross profit was $9.5 million for the second quarter of 2026, compared to $11.9 million in the prior-year period. For the first six months of 2026, gross profit was $15.9 million, compared to $21.8 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company's public company transition. Net income was $1.3 million, or $0.22 per diluted share, for the second quarter of 2026, compared to $2.6 million, or $1.45 per diluted share, in the second quarter of 2025. For the first six months of 2026, net income was $1.0 million, or $0.16 per diluted share, compared to $4.1 million, or $2.33 per diluted share, in the prior-year period. Adjusted EBITDA was $7.4 million for the second quarter of 2026, compared to $7.6 million in the prior-year period. For the first six months of 2026, Adjusted EBITDA was $12.2 million, compared to $13.0 million in the prior-year period. Adjusted diluted earnings per share was $0.66 for the second quarter of 2026, compared to $1.88 in the prior-year period. For the first six months of 2026, adjusted diluted earnings per share was $1.11, compared to $3.02 in the prior-year period. Affiliated Practice Updates As of June 30, 2026, we supported 87 affiliated practices and 219 affiliated doctors. Second quarter patient retention rate was 90.3%. Patient visits increased to 185,569 across our affiliated dental practices. During the second quarter our affiliated dental practices completed one general practice acquisition in Rochester, Minnesota, as previously announced on June 4, 2026. The acquired practices’ impact on revenues and net earnings was not material for the quarter. Entered into definitive agreement to acquire Village Family DSO, as announced on August 10, 2026. The Village Family DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. If completed, the transaction would mark our expansion into a fourth state, supporting an additional 48 doctors. The transaction is expected to close later this year. Balance Sheet, Liquidity, and Cash Flow Cash and cash equivalents were $24.4 million as of June 30, 2026. Total debt outstanding was approximately $11.0 million as of June 30, 2026, and our $15 million line of credit was undrawn at quarter end. Total shares outstanding were 4.7 million shares as of the end of the quarter. We generated $9.7 million in operating cash flow in the first half of 2026, an increase of $0.5 million compared to the prior year. Year-to-date capital investments were $4.8 million. Full-Year 2026 Outlook Based on our performance during the first half of 2026 and our current expectations for the remainder of the year, we are updating our full-year 2026 outlook. Our updated outlook does not contemplate the recently announced acquisition of Village Family Dental DSO, which remains subject to customary closing conditions and is expected to close later this year. Consistent with our historical approach, only completed acquisitions are incorporated into our outlook. Following the close of the transaction, we expect to evaluate its anticipated financial impact and provide an updated outlook at an appropriate time. Our revised outlook reflects continued confidence in the underlying performance of our affiliated practices, including patient demand, same-practice revenue growth, provider recruitment, and operational execution. Our outlook includes 3.5% to 5.0% organic revenue growth and approximately $2 million recurring public company costs, driven by increased legal, audit, and investor relation fees we expect to incur in 2026. The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand, industry and professional staffing trends that could impact our outlook. Conference Call As announced on July 20, 2026, the Company will host a conference call to discuss these results tomorrow morning, Thursday, August 13, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call. About Park Dental Partners, Inc. Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company has 219 affiliated doctors across 87 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today. Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com. Basis of Consolidation In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation. Forward Looking Statements Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as: Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations; Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors; Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions; Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities; Competition for patients and clinicians in our markets and the impact on patient volumes and staffing; Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets in which we operate. A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise. Non-GAAP Financial Measures This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company. Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results. See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP. Supplemental Financial Tables CONTACT: Company Contact Information Investor Contact: Park Dental Partners Investor Relations Team 763-233-3377 [email protected] Media Contact: Park Dental Partners Media Relations Team 651-633-0500 [email protected]

Image source: The Motley Fool. Thursday, May 14, 2026 at 8:30 a.m. ET Chief Executive Officer and Chair — Pete Swenson Chief Financial Officer — CJ Bernander Need a quote from a Motley Fool analyst? Email [email protected] Operator Morning, welcome to Park Dental Partners' first quarter 2026 earnings conference call. Today's call is being recorded, and at this time, all participants are in a listen-only mode. Following the prepared remarks, management will open the call for questions from its analysts. Certain statements made during the call today constitute forward-looking statements made pursuant to and within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the company's earnings press release issued yesterday and in the company's filings with the SEC. The forward-looking statements made today are as of the date of this call, and company does not undertake any obligation to update the forward-looking statements. Today's call will also include certain non-GAAP measurements. Please see the company's earnings press release for the reconciliation of those non-GAAP financial measures. The press release is available on the company's website. I will now turn the call over to Pete Swenson, Chief Executive Officer and Chair of the Board of Park Dental Partners. Pete Swenson Thank you, Tyler. Good morning, everyone, and thank you for joining Park Dental Partners' first quarter 2026 earnings call. Joining me today is our CFO, CJ Bernander. I'll start off by recognizing our doctors and team members across the organization. Our people are our greatest asset. Every day in every practice, you show up with a shared commitment to deliver the best patient experience to every patient every time. That consistency is the foundation of our reputation, our performance, and our ability to grow. I'm grateful for the professionalism and dedication our teams bring to patients and to one another. Our first quarter results were consistent with our expectations and reflect continued execution against the plan we outlined at the time of our IPO. We delivered a solid start to 2026, with revenue increasing 6.2% year-over-year, supported by healthy same-practice growth and continued patient demand across our markets. Growth in the quarter was driven by a combination of increased patient visits, expanded clinical hours, and continued growth in our provider base. Importantly, patient retention remains strong at just over 90%, reflecting the consistency of care and the relationships our affiliated doctors continue to build with their patients. We continue to execute on our growth strategy by adding providers within our existing practices, selectively acquiring new practices, and identifying future de novo location opportunities. Today, we have 221 doctors across three states, and we believe we can continue to grow that significantly over time. We believe in building market density over time to unlock operating efficiency, expand integrated specialty care services, and to strengthen our brands. Our approach to M&A is disciplined. Our strategy prioritizes cultural fit and focuses on opportunities that we believe have the potential for long-term value creation. Looking ahead, we intend to continue acquiring and opening de novo practices in existing markets to grow share while entering two to three new markets over the next few years with a land and expand playbook. During the quarter, we completed one acquisition and continue to see a healthy pipeline of opportunities that are aligned with our discipline around cultural fit and long-term value creation. The timing of acquisitions is difficult to predict, and while we strive to have a regular cadence of closings, we will not sacrifice our long-term goals to hit certain short-term metrics. We are patient-centered in everything we do, which leads to that high patient satisfaction and retention, and ultimately, that's what drives long-term value for our shareholders. As expected, our first quarter results reflect continued investment in clinical capacity, including recruiting, resources, staffing, and supporting our affiliated practices. Underlying performance was consistent with our expectations, and we believe these investments position us well for continued growth. With strong liquidity and a flexible balance sheet, we remain well positioned to continue executing on our growth strategy while maintaining a disciplined approach to capital allocation. I'll conclude my remarks by reiterating something that I hope resonates with all of our stakeholders. We have a patient-first culture. We think long term, and we are committed to keeping doctors at the center of governance and management. We continue to believe this will translate nicely to shareholder returns long term. Before I turn the call over to CJ, I would like to take a moment to recognize one of our clinical leaders and longtime colleague of ours, Dr. Alan Law. Dr. Law recently received the Edgar D. Coolidge Award from the American Association of Endodontists, the national specialty organization representing endodontics. This award is the AAE's highest honor. It is named after Dr. Edgar Coolidge, one of the pioneers of endodontics and an important figure in the establishment of the association. The award recognizes individuals whose careers reflect extraordinary vision, leadership, and a dedication to the specialty. For those of us at Park Dental Partners, Dr. Law's recognition is not a surprise. Dr. Law's work in the field of endodontics has benefited patients, doctors, educators, and the broader dental profession. It has also benefited Park Dental Partners. He has long represented the best of what it means to dedicate one's life to the profession of dentistry, clinical excellence, humility, service, and a commitment to advancing care for patients and colleagues. We are fortunate to have Dr. Law as a colleague and a leader, and we congratulate him on receiving one of the highest recognitions in his field. With that, I'll turn it over to CJ for the financial update. CJ Bernander Thanks, Pete. Good morning, everyone. For the first quarter, revenue was $62.7 million, representing growth of 6.2% year-over-year. Same practice revenue growth was 4.1%, driven by increased patient visits, clinical hours, and modest fee and reimbursement growth. Our general practice revenue grew 6.4% to $46.1 million, and our multi-specialty practice revenue grew 5.7% to $16.6 million. Overall, revenue growth in the quarter represents a combination of organic patient demand and continued expansion of our provider base. As expected, our first quarter results reflect continued focus on growing clinical capacity, including recruiting, staffing, and supporting our affiliated practices. On a GAAP basis, cost of services increased year-over-year, primarily reflecting higher share-based compensation following our IPO and increased doctor and team member costs aligned with the increased revenue growth. Restricted shares with IPO vesting triggers drove the higher share-based comp expense in Q1 as well as the last quarter, Q4. Of note, the expense is recognized using an accelerated method, not a straight line basis. Thus, share-based compensation related to pre-IPO shares will continue declining over the remaining quarters as they are fully recognized for GAAP purposes. As a reminder, doctor shareholders make up the majority of the share-based compensation expense, accounting for approximately 91% of share-based compensation in the quarter. General and administrative expenses increased modestly, driven by share-based compensation, public company costs, and acquisition-related activity. In the first quarter, on a GAAP basis, we recorded a net loss of $0.4 million or a $0.09 loss per share, compared with net income of $1.6 million or $0.88 per share in Q1 2025, respectively. On a non-GAAP basis, adjusted EBITDA was $4.7 million or 7.6% of revenue. Adjusted EPS was $0.44 per share. Year-over-year earnings declined due to the share-based compensation and absorbing public company costs, both of which were expected post-IPO and were partially offset by revenue growth and operating leverage. As we previously disclosed, our shares outstanding increased substantially as a result of the IPO. The year-over-year EPS comparisons are also impacted by that factor. Importantly, our expectations of public reporting costs and share-based compensation are consistent with what we have outlined on our last call. Overall, performance in the quarter was consistent with our expectations and we believe we're well positioned for continued growth. Turning to the balance sheet, we ended the quarter with $24.4 million in cash, $11.5 million in total debt, and an undrawn $15 million revolver. Operating cash flow was $5 million for the quarter. Our balance sheet remains a source of flexibility as we continue to invest in growth. Based on our first quarter performance, we are maintaining our full year 2026 outlook. Results in the quarter were consistent with our expectations. Our outlook continues to reflect solid patient demand and continued focus on expanding clinical capacity to support more patient visits. While we only provide an outlook on a full year basis, I would like to add some color on quarterly seasonality within 2026. For revenue, we expect Q2 to grow at a lower rate than Q1. Q3 and Q4 are expected to track at or above Q1's growth rate. This is driven by the timing of hiring across doctor and hygiene positions, which typically peak in the summer and align with the typical new grad timing. We also expect acquisitions closed at year-end 2025, and in the 1st quarter will be integrated by the 2nd half of the year. Overall, we're pleased with our start to the year and remain focused on high quality, recurring organic growth, disciplined M&A execution, and long-term value creation. Before I turn it back to Pete, I'd like to highlight two things. First, we will be filing our 10-Q after market close today. Secondly, Park Dental Partners will be attending the following investor conferences in the quarter. On May 27th, we'll be presenting at the Stifel Jaws & Paws Conference in New York. On May 28th, we'll be attending the Craig-Hallum Annual Institutional Investor Conference in Minneapolis, Minnesota. On June 23rd, we'll be participating virtually in the Northland Growth Conference. With that, I'll turn it back to Pete. Pete Swenson Thanks, CJ. We believe the first quarter reflects a continuation of the consistency we've delivered historically and reinforces the strength of our model. We're early in our journey as a public company, and our priorities remain unchanged. We're committed to our patients, our people, and our performance, all of which we believe will lead to long-term value creation for all stakeholders. We appreciate your time today and your continued interest in Park Dental Partners. Tyler, we're ready to take questions. Operator Thank you. Our first question comes from Mike Grondahl from Northland. Mike, your line is now open. Mike Grondahl Hey, Pete and CJ. Good morning. First question, I'd just like to dig into the acquisition pipeline a little bit. How does it look, say, compared to six months ago? Secondly, you know, as we've progressed through 2026, are there any deals that you've lost in 2026, and why potentially? Pete Swenson Thanks, Mike, and good morning. Appreciate the question. You know, I feel good about where things stand with regard to the pipeline. If you look at the pipeline today versus, say, a year ago, we have substantially more qualified opportunities that we're investing time into. We're seeing more opportunities of various sizes as well that are in the pipeline, from solo practices to midsize and some larger groups. Our team is very engaged in the process of evaluating those opportunities, and we're at various stages in the pipeline in pursuing opportunities. In regard to your question about 2026 and have we lost any deals, I would say not anything that we felt met all the criteria for us in terms of being a steward of that practice post-close. Things are competitive out there, but I think our model is being received well. It's just been a lot of fun meeting people that have built groups, built solo practices. There's some terrific people out there. Each of those, each of those opportunities is a little bit different, and just glad that we have a team, very experienced team here that can apply their skills and experience to evaluating those opportunities. Mike Grondahl Got it. Another question. Last summer, I think you hired about 10 or 12, and I don't have the exact number in front of me, but like recent graduates. Can you remind us what that number was last summer and what kind of the plans look like for this summer for those hires? CJ Bernander Mike, I'll take that one. I think that I don't know if we've disclosed the exact number, but we have a very strong pipeline process into the universities and the markets that we operate in to hire new grads into roles. It's one of our capacity growth drivers, and we're excited about that. We continue to operate and act in ways similar to last year. While I can't say we'll see similar levels of doctor growth or not, we feel good about the team that we have coming in and the new grads that have signed to join us. We're excited about their additions, and we hope to get a few more. As you know, the number of doctors is critical to a key metric of ours from a growth perspective. We feel like in Q1, we did see that number increase, and we're looking to just continue to expand it in the quarters as they go forward. There will be a little bit of seasonality in that. But we expect to see that number just continue to move up and to the right as the quarters roll out in the future here. Mike Grondahl Got it. Then maybe just lastly. Higher oil prices, a little bit of inflation out there. I gotta believe, you know, dental appointments and visits are kind of above that fray, if you will, and consumer spending pressure. Any comment just on the market we're in and what you guys are seeing? Pete Swenson Yeah, Mike, we're not seeing any changes in patient behavior at this time. It's something we continue to monitor. As you mentioned, there's a lot of dynamics happening in the macro environment, but what we've seen does not indicate to us that there's been material shifts or changes in patient visits or demand. Mike Grondahl Got it. Thank you. Operator Thank you. Pete Swenson Thanks, Mike. Operator Our next question comes from the line of Tollef Kohrman of Craig-Hallum. Tollef, the line is now open. Tollef Kohrman Hello, thank you for taking the questions. Are there any updates on potential de novo practices you could be opening? With the big leap into Arizona, can you talk about how the integration has been going? Thank you. Pete Swenson Yeah, CJ, maybe I'll let you take the first one. I'll answer the Arizona integration question. Our team, very experienced team of individuals, with decades of experience on our end, engaging really well with the teams in Arizona. Give you an example of a milestone we've reached here. We're going to be converting both of those practices to our practice management system, so we will have a common practice management system here within a couple of weeks. Those teams have been through our training, and things are going smoothly. It's a relationship building endeavor with integration, and one of our values is lifelong learning. I'd say that our team carries themselves with that at the forefront of their minds as we're engaging with integration activities. While we're experienced, we're also learning along the way and partnering with those practices. CJ Bernander Tol, to cover your question on de novo, similar to M&A, our practice is to announce de novo deals upon their opening. We don't typically provide or disclose future de novo activity. However, when those locations open, we would make that announcement. What I would add to that is, as we think about the broader market and revenue growth, I think Pete and I both feel like M&A and acquisitions are gonna be the larger lever from a growth perspective. We're still focused on de novo. We've got the capacity to go out and execute that playbook, and we see that as an opportunity to grow and expand our existing markets. We do expect that to be a smaller overall driver of growth, for the next number of quarters and M&A to be the larger driver. Tollef Kohrman Great. Thank you very much. Pete Swenson Thank you. Operator Thank you. I am showing no questions at this time. I would now like to turn it back to CJ Bernander for closing remarks. CJ Bernander Thank you for attending our earnings call. We appreciate the time and look forward to our next interaction with you. Have a great day, everyone. Operator This concludes the thank you for your participation in today's conference. This does conclude the program. You may now disconnect. Before you buy stock in Park Dental Partners, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Park Dental Partners wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $483,476!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,362,941!* Now, it’s worth noting Stock Advisor’s total average return is 998% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of May 19, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Park Dental (PARK) Q1 2026 Earnings Transcript was originally published by The Motley Fool

Interested in Park Dental Partners, Inc.? Here are five stocks we like better. Park Dental Partners reported first-quarter revenue of $62.7 million, up 6.2% year over year, with same-practice revenue growth of 4.1% driven by more patient visits, expanded clinical hours, and a larger provider base. The company posted a GAAP net loss of $0.4 million, compared with net income a year earlier, as IPO-related public company costs and share-based compensation weighed on results; adjusted EBITDA was $4.7 million, or 7.6% of revenue. Management maintained its full-year outlook and said patient demand remains steady, while acquisitions remain a key growth focus with a stronger pipeline and ongoing integration work in Arizona. Park Dental Partners (NASDAQ:PARK) reported a 6.2% year-over-year increase in first-quarter revenue and said patient demand remained steady as the newly public dental services company continued to invest in clinical capacity and pursue acquisitions. Chief Executive Officer and Chair Pete Swenson said the company’s first-quarter results were “consistent with our expectations” and reflected execution against the plan management outlined at the time of its IPO. Revenue for the quarter was $62.7 million, with same-practice revenue growth of 4.1%. → Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe? Swenson said growth was supported by increased patient visits, expanded clinical hours and continued growth in the provider base. He also said patient retention remained strong at just over 90%. “We delivered a solid start to 2026, with revenue increasing 6.2% year-over-year, supported by healthy same-practice growth and continued patient demand across our markets,” Swenson said. → MP Materials Is Quietly Building a Rare Earth Powerhouse Chief Financial Officer CJ Bernander said general practice revenue grew 6.4% to $46.1 million, while multi-specialty practice revenue increased 5.7% to $16.6 million. Same-practice revenue growth was driven by increased patient visits, additional clinical hours and modest fee and reimbursement growth. Bernander said overall revenue growth reflected organic patient demand and expansion of the company’s provider base. Park Dental Partners ended the quarter with 221 doctors across three states, according to Swenson. → Micron Investors Face a High-Stakes Moment After the Latest Rally The company recorded a GAAP net loss of $0.4 million, or a loss of $0.09 per share, compared with net income of $1.6 million, or $0.88 per share, in the first quarter of 2025. On a non-GAAP basis, adjusted EBITDA was $4.7 million, or 7.6% of revenue, and adjusted EPS was $0.44. Bernander said year-over-year earnings declined due to share-based compensation and public company costs following the IPO, partially offset by revenue growth and operating leverage. He also noted that EPS comparisons were affected by a substantial increase in shares outstanding after the IPO. Management said share-based compensation was elevated in the quarter due to restricted shares with IPO vesting triggers. Bernander said doctor shareholders accounted for approximately 91% of share-based compensation in the quarter and that expense related to pre-IPO shares is expected to decline over the remaining quarters as it is recognized for GAAP purposes. Park Dental Partners maintained its full-year 2026 outlook, saying first-quarter performance was in line with expectations. Management did not provide new annual guidance figures on the call. Bernander said the company continues to expect solid patient demand and is focused on expanding clinical capacity to support additional visits. He also provided commentary on quarterly seasonality, saying revenue growth in the second quarter is expected to be lower than in the first quarter, while growth in the third and fourth quarters is expected to be at or above the first-quarter growth rate. He attributed that expected pattern to the timing of hiring across doctor and hygiene positions, which typically peaks in the summer and aligns with the timing of new graduates entering the workforce. Bernander also said acquisitions completed at the end of 2025 and in the first quarter of 2026 are expected to be integrated by the second half of the year. At quarter-end, the company had $24.4 million in cash, $11.5 million in total debt and an undrawn $15 million revolver. Operating cash flow was $5 million for the quarter. Bernander said the balance sheet “remains a source of flexibility” as the company invests in growth. Swenson said Park Dental Partners continues to pursue growth by adding providers within existing practices, selectively acquiring new practices and identifying future de novo location opportunities. During the quarter, the company completed one acquisition. Swenson said the company’s merger-and-acquisition strategy remains disciplined, with an emphasis on cultural fit and long-term value creation. He said the timing of acquisitions is difficult to predict and that management does not intend to pursue deals simply to meet short-term metrics. “While we strive to have a regular cadence of closings, we will not sacrifice our long-term goals to hit certain short-term metrics,” Swenson said. In response to a question from Northland analyst Mike Grondahl, Swenson said the acquisition pipeline is stronger than it was a year ago, with “substantially more qualified opportunities” under evaluation. He said the company is seeing opportunities across a range of sizes, including solo practices, midsize practices and larger groups. Asked whether the company had lost any deals in 2026, Swenson said not any that met all of Park Dental Partners’ criteria for stewardship after closing. He said the market is competitive but that the company’s model is being received well. Management said acquisitions are expected to be the larger growth lever over the next several quarters, though de novo locations remain part of the company’s growth strategy. In response to a question from Craig-Hallum analyst Tollef Kohrman, management said Park Dental Partners typically announces de novo practices when they open and does not disclose future de novo activity in advance. Swenson also discussed the company’s integration efforts in Arizona, saying teams there are engaging well with Park Dental Partners’ integration team. He said the company is preparing to convert both Arizona practices to its practice management system, creating a common platform within a couple of weeks. Swenson described integration as a “relationship building endeavor” and said the company is approaching the process with an emphasis on learning and partnership. Asked about consumer spending pressures, inflation and higher oil prices, Swenson said Park Dental Partners had not seen changes in patient behavior. He said management continues to monitor macroeconomic dynamics but has not observed material shifts in patient visits or demand. Swenson emphasized the company’s patient-first culture and said he believes its doctor-centered governance and management approach will support long-term shareholder returns. “We’re early in our journey as a public company, and our priorities remain unchanged,” Swenson said. “We’re committed to our patients, our people, and our performance, all of which we believe will lead to long-term value creation for all stakeholders.” Park Dental Partners (NASDAQ: PARK) is a dental support organization that provides business and administrative services to affiliated dental practices. The company focuses on enabling dental clinicians to concentrate on patient care by delivering centralized non-clinical functions that support day-to-day operations and practice growth. Services typically offered by Park Dental Partners include practice management, billing and revenue cycle management, procurement and supply-chain support, information technology, human resources, marketing and patient acquisition, and regulatory and compliance assistance. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Park Dental Partners Q1 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.

MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables. (a) See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below (b) See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA below (c) See Non GAAP Reconciliation of Earnings (Loss) Per Share to Adjusted Earnings Per Share below Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors “We delivered a solid start to 2026, with revenue increasing 6.2% year over year, driven by strong same practice performance and continued patient demand. Results were consistent with our expectations and reflect continued execution against our operating plan. We continue to invest in recruiting, staffing, and clinical capacity to support long-term growth. With strong liquidity and a flexible balance sheet, we remain well positioned to execute on our growth strategy, including expanding current practices and adding new practices through disciplined acquisitions and de novo expansion.” Financial Results – First Quarter 2026 Revenue increased 6.2% over the prior year’s comparable quarter to $62.7 million, due to increased patient visits and growth in clinical hours, the impact of acquisitions and reimbursement growth. Same practice revenue growth was 4.1%. Revenue from acquisitions in the past 12 months contributed approximately $0.8 million in the quarter. Total General Practice revenue grew 6.4% over the prior year’s comparable quarter to $46.1 million. Total Multi-Specialty Practice revenue grew 5.7% to $16.6 million. Cost of services was $56.3 million, an increase of $7.1 million above the prior year’s comparable quarter, driven primarily by share-based compensation recorded in the quarter and growth in doctors and team members. General and administrative costs were $7.8 million, an increase of $0.9 million above the prior year’s comparable quarter. The primary driver of these increases was share-based compensation, acquisition-related costs, and public company costs, net of lower IPO preparation costs related to our 2025 offering. Net loss was $(0.4) million, compared to net income of $1.6 million in the prior year comparable quarter, primarily driven by increased salaries and benefits, and share-based compensation, partially offset by revenue growth, tax benefits on share-based compensation, and operating leverage. Adjusted EBITDA was $4.7 million, or 7.6% of revenue, compared to $5.5 million, or 9.3% of revenue in the prior year comparable quarter. Adjusted diluted earnings per share were $0.44 versus $1.14 in the prior year’s comparable quarter, due primarily to the increase in shares issued and vested during the IPO. Affiliated Practice Updates As of March 31, 2026, we supported 86 affiliated practices and 221 affiliated doctors. First quarter patient retention rate was 90.1%. Patient visits increased to 178,527 across our affiliated dental practices. During the first quarter our affiliated dental practices completed one general practice acquisition in Tucson, Arizona, as previously announced on January 23, 2026. The acquired practices’ impact on revenues and net earnings was not material for the quarter. Balance Sheet, Liquidity, and Cash Flow Cash and cash equivalents were $24.4 million as of March 31, 2026. Total debt outstanding was approximately $11.5 million as of March 31, 2026, and our $15 million line of credit was undrawn at quarter end. Total shares outstanding were 4.5 million shares as of the end of the quarter. We generated $5.0 million in operating cash flow in the first quarter, a decrease of $0.8 million compared to the prior year comparable quarter due primarily to changes in working capital. First quarter capital investments were $2.3 million. Full-Year 2026 Outlook First quarter results were consistent with our expectations, and we are maintaining our fiscal 2026 outlook range. Our outlook excludes the impact of any future practice affiliations or acquisitions that have not yet closed. As a result, actual results may differ materially depending on the timing and number of future affiliations, de novo practice openings, or acquisitions completed during the year. Our outlook includes 3.5% to 5.0% same practice revenue growth and approximately $2 million recurring public company costs we expect to incur in 2026. The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand and labor market trends that could impact our outlook. Conference Call As announced on April 24, 2026, the Company will host a conference call to discuss these results tomorrow morning, Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call. About Park Dental Partners, Inc. Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company has 221 affiliated doctors across 86 practice locations in three states. The Company’s clinical support team consists of approximately 990 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today. Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com. Basis of Consolidation In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation. Forward Looking Statements Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as: Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations; Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors; Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions; Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities; Competition for patients and clinicians in our markets and the impact on patient volumes and staffing; Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets we operate. A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise. Non-GAAP Financial Measures This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company. Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results. See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP. Supplemental Financial Tables CONTACT: Company Contact Information Investor Contact: Park Dental Partners Investor Relations Team 763-233-3377 [email protected] Media Contact: Park Dental Partners Media Relations Team 651-633-0500 [email protected]